PSX reports Q1 results April 29 with the stock down 11.6% over the past month, trading at $162.85. Short interest has fallen sharply in parallel — down 23.5% from late March levels to just 1.6% of the float. Borrow costs remain negligible at 0.36%, and utilisation sits at 0.32%, far below the 52-week high of 5.2% recorded earlier in the year. Options positioning has tilted slightly more cautious, with the put/call ratio running above its 20-day average at 0.90, though still well within normal bounds. The stock rose 4.1% over the past week even as peer refiners MPC and VLO posted similar gains, suggesting sector-wide rather than company-specific forces at work.
The Street has been raising targets aggressively heading into the print. Morgan Stanley upgraded to Overweight on April 24, lifting its price target from $147 to $174. That followed a wave of bullish adjustments earlier in the month — UBS raised to $212, Wells Fargo to $201, Raymond James to $205 — all maintaining Buy-equivalent ratings while acknowledging stronger refining fundamentals. Yet consensus remains stuck at Hold, with nine neutral ratings offsetting just three Buys. The mean target of $181 implies 11% upside from current levels. Bulls point to the company's 99% utilisation rate and 88% clean product yield in Q4, plus the expectation that equity volumes will climb to 40% over the next 18 months and structural improvements could lift EBITDA from $4.0 billion toward $4.5 billion by 2027. Bears counter that Q1 estimates have been cut — EPS now pegged at $1.75, EBITDA at $759 million — on weaker refining margins and Gulf Coast pricing pressure. Midstream EBITDA also took a hit from winter storm downtime and accelerated Permian depreciation.
Institutional holders added steadily through Q1. State Street lifted its stake by 1.7 million shares, BlackRock by 695,000. Elliott Management remains the largest active holder at 4.8% with 19.3 million shares, unchanged since December. Insiders sold heavily over the past 90 days, unloading nearly $32.5 million net across executive ranks. CFO Kevin Mitchell sold twice in early March for a combined $3.7 million, and EVP Brian Mandell offloaded $7.3 million mid-March. The company historically rallies into earnings — the last three prints averaged a 9% five-day gain — though the February report moved just 4.3% higher on day one. Factor scores are mixed: EPS surprise ranks in the 93rd percentile and dividend score at the 91st, but forward EPS growth momentum sits in the 23rd percentile. The earnings announcement will test whether the recent target-price wave reflects genuine confidence in margin recovery or simply a mechanical reset after a steep drawdown that left valuation multiples compressed.
See the live data behind this article on ORTEX.
Open PSX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
